Zylox-Tonbridge Medical Technology Co., Ltd. (818.F)

1,1600 -0,0500 (-4,13%) Börsenschluss: 03:29PM CEST

Zylox-Tonbridge Medical Technology Co., Ltd.

Zylox-Tonbridge Industrial Park
No. 270 Shuyun Road Cangqian Street Yuhang District
Hangzhou
China
86 571 8861 0082
https://www.zyloxtb.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 765

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Zhong Zhao	Founder, Chairman & CEO	653,88k	N/A	1968
Mr. Yang Xie	Senior VP of Sales & Marketing and Executive Director	528,95k	N/A	1970
Dr. Zheng Li	Senior VP, GM of Neurovascular Business & Executive Director	573,89k	N/A	1978
Mr. Quanwei Yuan	CFO & Joint Company Secretary	N/A	N/A	1980
Ms. Sau In Kwan	Joint Company Secretary	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services, as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.

Corporate Governance

Zylox-Tonbridge Medical Technology Co., Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.